金石亚药：关于全资子公司获得硫酸氨基葡萄糖胶囊药品注册证书的公告

Core Viewpoint - The company has received approval for its glucosamine sulfate capsule from the National Medical Products Administration, which is considered equivalent to passing the consistency evaluation [2]. Group 1 - The company, Sichuan Jinshi Asia Pharmaceutical Co., Ltd., announced that its wholly-owned subsidiary, Zhejiang Yake Pharmaceutical Co., Ltd., has been granted a drug registration certificate for glucosamine sulfate capsules [2].